BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 3971297)

  • 1. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study.
    Minton JP; Hoehn JL; Gerber DM; Horsley JS; Connolly DP; Salwan F; Fletcher WS; Cruz AB; Gatchell FG; Oviedo M
    Cancer; 1985 Mar; 55(6):1284-90. PubMed ID: 3971297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery.
    Fucini C; Tommasi SM; Rosi S; Malatantis G; Cardona G; Panichi S; Bettini U
    Dis Colon Rectum; 1987 Apr; 30(4):273-7. PubMed ID: 3470172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of CEA-initiated second-look surgery for recurrent colorectal cancer.
    Steele G; Zamcheck N; Wilson R; Mayer R; Lokich J; Rau P; Maltz J
    Am J Surg; 1980 Apr; 139(4):544-8. PubMed ID: 7369462
    [No Abstract]   [Full Text] [Related]  

  • 4. CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma.
    Martin EW; Minton JP; Carey LC
    Ann Surg; 1985 Sep; 202(3):310-7. PubMed ID: 4037904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CEA monitoring in the follow-up of colorectal cancer patients with negative preoperative serum CEA.
    Mariani G; Carmellini M; Bonaguidi F; Benelli MA; Toni MG
    Eur J Cancer (1965); 1980 Aug; 16(8):1099-103. PubMed ID: 7439224
    [No Abstract]   [Full Text] [Related]  

  • 6. Preoperative carcinoembryonic antigen and prognosis in patients with colorectal cancer.
    Onetto M; Paganuzzi M; Secco GB; Fardelli R; Santi F; Rovida S; Ferrara GB
    Biomed Pharmacother; 1985; 39(7):392-5. PubMed ID: 3830268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoembryonic antigen and recurrent colorectal cancer.
    Northover JM
    Br J Surg; 1985 Sep; 72 Suppl():S44-6. PubMed ID: 3899260
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer.
    Wood CB; Ratcliffe JG; Burt RW; Malcolm AJ; Blumgart LH
    Br J Surg; 1980 Jan; 67(1):46-8. PubMed ID: 7357243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma.
    Boey J; Cheung HC; Lai CK; Wong J
    World J Surg; 1984 Jun; 8(3):279-86. PubMed ID: 6464483
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prognostic value of postoperative determination of CEA in carcinoma of the large intestine].
    Florianello F; Gorla C; Biraghi T; Caron R; Scortecci V
    Minerva Med; 1986 Apr; 77(18):739-41. PubMed ID: 3714087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recurrence in Dukes stages B2 and C colorectal cancers.
    Koch M; Washer G; Gaedke H; McPherson TA
    J Natl Cancer Inst; 1982 Oct; 69(4):813-5. PubMed ID: 6956758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential antitumour immunoreactivity and carcinoembryonic antigen levels as a guide to prognosis in colorectal carcinoma.
    Nairn RC; Nind AP; Pihl E; Ceredig R; Jablonka IM; Cuthbertson AM; Hughes ES; Rollo AJ
    Aust N Z J Surg; 1977 Oct; 47(5):637-41. PubMed ID: 273407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of CEA in colorectal carcinoma].
    Shimoyama T; Fukuda Y; Itoh S; Shimizu T; Kawaguchi A; Mori M; Ishii T; Miura T; Tomita M
    Gan No Rinsho; 1985 May; 31(6 Suppl):648-54. PubMed ID: 3897618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of CEA monitoring as a guide to second-look surgery in colorectal cancer follow-up.
    Fucini C; Tommasi MS; Cardona G; Malatantis G; Panichi S; Bettini U
    Tumori; 1983 Aug; 69(4):359-64. PubMed ID: 6623661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEA directed second-look surgery for colon and rectal cancer.
    Minton J; Chevinsky AH
    Ann Chir Gynaecol; 1989; 78(1):32-7. PubMed ID: 2667446
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristics of adenocarcinomas of the colorectum with low levels of preoperative plasma carcinoembryonic antigen (CEA).
    Jubert AV; Talbott TM; Maycroft TM
    Cancer; 1978 Aug; 42(2):635-9. PubMed ID: 679156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer.
    Wanebo JH; Stearns M; Schwartz MK
    Ann Surg; 1978 Oct; 188(4):481-93. PubMed ID: 697433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].
    Wählby L
    Lakartidningen; 1997 Apr; 94(18):1716-8. PubMed ID: 9182180
    [No Abstract]   [Full Text] [Related]  

  • 19. Carcinoembryonic antigen levels as an indicator for reoperation in patients with carcinoma of the colon and rectum.
    Cohen AM; Wood WC
    Surg Gynecol Obstet; 1979 Jul; 149(1):22-6. PubMed ID: 451823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer?
    Wanebo HJ
    Surgery; 1981 Mar; 89(3):290-5. PubMed ID: 7466616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.